title: Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection.
authors.affiliation: From the *Graham Hughes Lupus Research Laboratory, Lupus Research Unit, The Rayne Institute, Division of Women's Health, King's College London, London, United Kingdom; †Centro di Ricerche di Immunologia Clinica ed Immunopatologia e Documentazione su Malattie Rare, Università di Torino, Turin, Italy; and ‡Louise Coote Lupus Unit, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, London, United Kingdom.
authors.forename: Joana
authors.initials: J
authors.lastname: Simoes
authors.forename: Savino
authors.initials: S
authors.lastname: Sciascia
authors.forename: Ines
authors.initials: I
authors.lastname: Camara
authors.forename: Simone
authors.initials: S
authors.lastname: Baldovino
authors.forename: Yousuf
authors.initials: Y
authors.lastname: Karim
authors.forename: Dario
authors.initials: D
authors.lastname: Roccatello
authors.forename: Maria Jose
authors.initials: MJ
authors.lastname: Cuadrado
mesh_terms: D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy*; D015897:Comorbidity; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy; D012189:Retrospective Studies; D016896:Treatment Outcome; D014657:Vasculitis / Q000150:complications / Q000188:drug therapy*
chemical_list: D016756:Immunoglobulins, Intravenous